Metformin and Time to Sustained Recovery in Adults With COVID-19

Overview of attention for article published in JAMA Internal Medicine, September 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs: 3 blogs
twitter: 15 X users
facebook: 1 Facebook page
reddit: 1 Redditor

video: 1 YouTube creator
bluesky: 13 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 14 Bluesky posts from 13 Bluesky users, with an upper bound of 33,084 followers.

Ein Paper, was keine Wirksamkeit von Metformin in der Covid-Akutphase nachgewiesen hat, wurde zurückgezogen. Es gibt allerdings ein anderes mit ähnlichem Ergebnis: jamanetwork.com/journals/jam... Beide beziehen sich aber nicht auf die Risikoreduktion bzgl…

In adults with acute mild to moderate #COVID19, metformin did not shorten recovery time compared to placebo, with similar median times to symptom resolution in both groups. ja.ma/3UWpQHi

on en est encore à ce genre de truc ?! Metformin and Time to Sustained Recovery in Adults With COVID-19The ACTIV-6 Randomized Clinical Trial Ne perdez pas de temps, ça ne marche pas. Belle (non) tentative de spin dans le conclusion. @chercheurjuteux.…

#Evidence that #metformin is not effective against #COVID19. #Covid #Corona #MedSky 🧪

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 10 additional Bluesky posts.